Phibro Animal Health Corporation (NASDAQ:PAHC) Shareholders Set to Receive $0.12 Quarterly Dividend

Phibro Animal Health Corporation (NASDAQ:PAHC) announced a quarterly dividend on Tuesday, November 3rd. Stockholders of record on Wednesday, November 25th will be given a dividend of $0.12 per share on Wednesday, December 16th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Wednesday, November 25th.

Phibro Animal Health has a payout ratio of 23.9% meaning its dividend is sufficiently covered by earnings. Research analysts expect Phibro Animal Health to earn $3.81 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 12.6%.

Phibro Animal Health Stock Down 2.8%

PAHC stock opened at $37.65 on Wednesday. Phibro Animal Health has a 52 week low of $28.25 and a 52 week high of $60.08. The company has a quick ratio of 1.27, a current ratio of 2.96 and a debt-to-equity ratio of 1.84. The firm has a 50-day simple moving average of $37.09 and a 200-day simple moving average of $41.10. The stock has a market capitalization of $1.53 billion, a P/E ratio of 15.43 and a beta of 0.42.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, August 26th. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.14. Phibro Animal Health had a net margin of 6.57% and a return on equity of 37.86%. The firm had revenue of $396.75 million for the quarter, compared to analyst estimates of $381.18 million. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS. Equities analysts forecast that Phibro Animal Health will post 3.49 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

PAHC has been the subject of several research reports. Zacks Research upgraded Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 18th. Weiss Ratings upgraded Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Phibro Animal Health has a consensus rating of “Buy” and an average target price of $47.67.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture.

The company’s products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions.

Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets.